3 ASX 200 healthcare shares to buy with 35% to 103% upside ahead
AI Market Summary
Telix reported 19% year-on-year Q3 revenue growth and reaffirmed full-year guidance, yet its shares have fallen about 19% since last Tuesday. The divergence highlights company-specific volatility in ASX healthcare rather than broad market stress. With no directly mapped symbol in the asset list, the read-through is limited for the wider market.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+0.82%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
ASX 200 healthcare shares have rebounded strongly since mid-2026. Here are three which are tipped to keep climbing higher.